FDA planning Tuesday opioid announcement

FDA alerted manufacturers of extended-release and long-acting opioids to expect "significant action" on Tuesday regarding the products, according to an email obtained by BioCentury. The agency could not be reached for details on the announcement but could be announcing changes to its classwide REMS for the products (see BioCentury Extra, July 9, 2012). ...